Join
Live feed
·
INSIDERFilingvia Quantisnow
Theravance Biopharma Inc. logo

Director O'Connor Donal returned 80,213 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4) (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TBPH (Theravance Biopharma Inc.) and more on Quantisnow.